78.1% Vaccination Completion Rate per Population
32.7% Vaccination Reservation Rate for Ages 12-15
One Additional Teen Death Reported on the 11th

On the 12th, when the additional COVID-19 booster vaccinations for workers at treatment hospitals began, medical staff and other workers at the National Medical Center in Jung-gu, Seoul, were observed for adverse reactions after receiving the vaccine. Photo by Hyunmin Kim kimhyun81@

On the 12th, when the additional COVID-19 booster vaccinations for workers at treatment hospitals began, medical staff and other workers at the National Medical Center in Jung-gu, Seoul, were observed for adverse reactions after receiving the vaccine. Photo by Hyunmin Kim kimhyun81@

View original image


[Asia Economy Reporter Han Jinju] The number of people who have completed COVID-19 vaccination in South Korea has surpassed 40 million. It has been 260 days since the vaccination began.


On the 13th, the COVID-19 Vaccination Response Promotion Team announced that as of 12 noon on that day, 40,080,591 people had received the recommended doses of the COVID-19 vaccine. The vaccination completion rate compared to the population of South Korea (51,349,116 as of the end of last year) is 78.1%.


As of midnight on the same day, the highest vaccination completion rate was among those in their 60s at 94.3%. Next were ▲50s at 94.2% ▲70s at 92.8% ▲40s at 89.7% ▲18?29 years old at 87.8% ▲30s at 85.5% ▲80 and older at 82.2%. The 12?17 age group, whose vaccination started late, was at 6.2%.


The number of people who received the first dose as of 12 noon on the same day was 41,951,125, which is about 81.7% of the population.


For ages 16?17, 615,200 people had completed the first dose by midnight on that day. The number of people who completed the second dose was 166,945.


For ages 12?15, 283,978 people completed the first dose, and 3,370 completed the second dose.


Vaccination reservations for ages 12?15 closed at 6 p.m. the previous day. The reservation rate was 32.7%.


Among those who received booster shots, 345,736 people who had initially received a single dose of the Janssen vaccine completed the additional vaccination.


Additional vaccinations were also administered to 339,206 elderly aged 60 and above and high-risk groups, 188,954 immunocompromised individuals, 110,605 COVID-19 treatment hospital workers, 1,036 priority occupation groups, 369 people in their 50s, and 8 people aged 18?49 with underlying conditions.


The number of new cases reported to health authorities as suspected adverse reactions after vaccination was 3,937 over the three days from the 10th to the 12th.


According to the Promotion Team, one additional death report involving a teenager was received on the 11th. This is the second reported death case among teenagers after vaccination. The first was a teenage male vaccinated on August 20, who died on the 31st of last month, 72 days after vaccination.


The authorities plan to investigate the causal relationship between vaccination and death. Including this male, 15 death reports were added over the past three days.


Reports of suspected anaphylaxis, a severe systemic allergic reaction, increased by 27 cases. Major adverse reaction cases such as neurological abnormalities were newly reported in 108 cases.



Since the start of vaccination in South Korea on February 26 of this year, the cumulative number of suspected adverse reaction reports is 373,568 (including 891 cumulative deaths). As of midnight on the same day, this represents about 0.46% of the cumulative vaccination doses administered (81,394,840 doses).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing